Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+367K
-
Total reported value, excl. options
-
$116M
-
Value change
-
+$4.73M
-
Number of buys
-
24
-
Number of sells
-
-13
-
Price
-
$11.39
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q1 2019
52 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q1 2019.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 84.7M outstanding shares and own 13.26% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (1.82M shares), CITADEL ADVISORS LLC (1.73M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.24M shares), Samsara BioCapital, LLC (1.13M shares), VV Manager LLC (996K shares), Tekla Capital Management LLC (641K shares), Camber Capital Management LP (600K shares), SPHERA FUNDS MANAGEMENT LTD. (438K shares), FMR LLC (400K shares), and Sio Capital Management, LLC (399K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.